284 related articles for article (PubMed ID: 30597288)
1. Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells.
Kosgodage US; Uysal-Onganer P; MacLatchy A; Mould R; Nunn AV; Guy GW; Kraev I; Chatterton NP; Thomas EL; Inal JM; Bell JD; Lange S
Transl Oncol; 2019 Mar; 12(3):513-522. PubMed ID: 30597288
[TBL] [Abstract][Full Text] [Related]
2. Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.
Uysal-Onganer P; MacLatchy A; Mahmoud R; Kraev I; Thompson PR; Inal JM; Lange S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098295
[TBL] [Abstract][Full Text] [Related]
3. Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.
Kosgodage US; Uysal-Onganer P; MacLatchy A; Kraev I; Chatterton NP; Nicholas AP; Inal JM; Lange S
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597867
[TBL] [Abstract][Full Text] [Related]
4. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G
Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736
[TBL] [Abstract][Full Text] [Related]
5. Proteomics of Extracellular Vesicle in Glioblastoma.
Lee YJ; Seo CW; Lee D; Choi D
Brain Tumor Res Treat; 2022 Oct; 10(4):207-214. PubMed ID: 36347634
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 Upregulated by Temozolomide in Glioblastoma Cells Is Shuttled In Extracellular Vesicles Modifying Recipient Cell Phenotype.
Lombardi F; Augello FR; Artone S; Ayroldi E; Giusti I; Dolo V; Cifone MG; Cinque B; Palumbo P
Front Oncol; 2022; 12():933746. PubMed ID: 35936755
[TBL] [Abstract][Full Text] [Related]
7. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
[TBL] [Abstract][Full Text] [Related]
10. Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents.
Nabissi M; Morelli MB; Santoni M; Santoni G
Carcinogenesis; 2013 Jan; 34(1):48-57. PubMed ID: 23079154
[TBL] [Abstract][Full Text] [Related]
11. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma.
López-Valero I; Torres S; Salazar-Roa M; García-Taboada E; Hernández-Tiedra S; Guzmán M; Sepúlveda JM; Velasco G; Lorente M
Biochem Pharmacol; 2018 Nov; 157():275-284. PubMed ID: 30125556
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype.
Oushy S; Hellwinkel JE; Wang M; Nguyen GJ; Gunaydin D; Harland TA; Anchordoquy TJ; Graner MW
Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1737):. PubMed ID: 29158308
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation.
Choi D; Lee TH; Spinelli C; Chennakrishnaiah S; D'Asti E; Rak J
Semin Cell Dev Biol; 2017 Jul; 67():11-22. PubMed ID: 28077296
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide affects Extracellular Vesicles Released by Glioblastoma Cells.
André-Grégoire G; Bidère N; Gavard J
Biochimie; 2018 Dec; 155():11-15. PubMed ID: 29454008
[TBL] [Abstract][Full Text] [Related]
15. Molecular subtypes and differentiation programmes of glioma stem cells as determinants of extracellular vesicle profiles and endothelial cell-stimulating activities.
Spinelli C; Montermini L; Meehan B; Brisson AR; Tan S; Choi D; Nakano I; Rak J
J Extracell Vesicles; 2018; 7(1):1490144. PubMed ID: 30034643
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture.
Deng L; Ng L; Ozawa T; Stella N
J Pharmacol Exp Ther; 2017 Jan; 360(1):215-224. PubMed ID: 27821713
[TBL] [Abstract][Full Text] [Related]
17. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer.
Kosgodage US; Mould R; Henley AB; Nunn AV; Guy GW; Thomas EL; Inal JM; Bell JD; Lange S
Front Pharmacol; 2018; 9():889. PubMed ID: 30150937
[TBL] [Abstract][Full Text] [Related]
19. CD9- and CD81-positive extracellular vesicles provide a marker to monitor glioblastoma cell response to photon-based and proton-based radiotherapy.
Jennrich S; Pelzer M; Tertel T; Koska B; Vüllings M; Thakur BK; Jendrossek V; Timmermann B; Giebel B; Rudner J
Front Oncol; 2022; 12():947439. PubMed ID: 36203458
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.
Wang H; Cai S; Bailey BJ; Reza Saadatzadeh M; Ding J; Tonsing-Carter E; Georgiadis TM; Zachary Gunter T; Long EC; Minto RE; Gordon KR; Sen SE; Cai W; Eitel JA; Waning DL; Bringman LR; Wells CD; Murray ME; Sarkaria JN; Gelbert LM; Jones DR; Cohen-Gadol AA; Mayo LD; Shannon HE; Pollok KE
J Neurosurg; 2017 Feb; 126(2):446-459. PubMed ID: 27177180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
